22nd Century Group Past Earnings Performance
Past criteria checks 0/6
22nd Century Group's earnings have been declining at an average annual rate of -19.7%, while the Tobacco industry saw earnings growing at 9.6% annually. Revenues have been declining at an average rate of 4.2% per year.
Key information
-19.7%
Earnings growth rate
8.7%
EPS growth rate
Tobacco Industry Growth | 18.1% |
Revenue growth rate | -4.2% |
Return on equity | -959.6% |
Net Margin | -289.5% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Market Participants Recognise 22nd Century Group, Inc.'s (NASDAQ:XXII) Revenues Pushing Shares 1,233% Higher
Apr 02Time To Worry? Analysts Just Downgraded Their 22nd Century Group, Inc. (NASDAQ:XXII) Outlook
Aug 20With 22nd Century Group, Inc. (NASDAQ:XXII) It Looks Like You'll Get What You Pay For
Jun 14Does 22nd Century Group (NASDAQ:XXII) Have A Healthy Balance Sheet?
Jan 1322nd Century adds Creager as distribution partner for its VLN cigarettes in Colorado
Oct 03Revenue & Expenses Breakdown
How 22nd Century Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 17 | -50 | 12 | 1 |
30 Jun 24 | 19 | -51 | 17 | 2 |
31 Mar 24 | 19 | -63 | 24 | 2 |
31 Dec 23 | 22 | -65 | 31 | 3 |
30 Sep 23 | 19 | -37 | 28 | 1 |
30 Jun 23 | 27 | -41 | 36 | 2 |
31 Mar 23 | 30 | -38 | 35 | 3 |
31 Dec 22 | 28 | -37 | 32 | 4 |
30 Sep 22 | 49 | -47 | 39 | 5 |
30 Jun 22 | 39 | -44 | 31 | 5 |
31 Mar 22 | 30 | -36 | 28 | 4 |
31 Dec 21 | 31 | -33 | 26 | 4 |
30 Sep 21 | 23 | -25 | 23 | 4 |
30 Jun 21 | 25 | -20 | 19 | 4 |
31 Mar 21 | 28 | -21 | 17 | 4 |
31 Dec 20 | 28 | -20 | 15 | 4 |
30 Sep 20 | 28 | -20 | 13 | 4 |
30 Jun 20 | 27 | -26 | 14 | 6 |
31 Mar 20 | 27 | -29 | 13 | 7 |
31 Dec 19 | 26 | -27 | 13 | 8 |
30 Sep 19 | 26 | -29 | 11 | 10 |
30 Jun 19 | 26 | -13 | 9 | 12 |
31 Mar 19 | 27 | -11 | 9 | 15 |
31 Dec 18 | 26 | -8 | 9 | 15 |
30 Sep 18 | 25 | -3 | 9 | 13 |
30 Jun 18 | 24 | -12 | 9 | 9 |
31 Mar 18 | 20 | -9 | 9 | 5 |
31 Dec 17 | 17 | -13 | 8 | 3 |
30 Sep 17 | 14 | -12 | 8 | 3 |
30 Jun 17 | 13 | -11 | 7 | 3 |
31 Mar 17 | 11 | -11 | 7 | 2 |
31 Dec 16 | 12 | -12 | 8 | 2 |
30 Sep 16 | 12 | -12 | 8 | 2 |
30 Jun 16 | 11 | -12 | 8 | 2 |
31 Mar 16 | 11 | -10 | 8 | 2 |
31 Dec 15 | 9 | -11 | 9 | 2 |
30 Sep 15 | 6 | -14 | 11 | 1 |
30 Jun 15 | 3 | -14 | 12 | 1 |
31 Mar 15 | 1 | -14 | 12 | 1 |
31 Dec 14 | 1 | -16 | 9 | 1 |
30 Sep 14 | 8 | -18 | 6 | 1 |
30 Jun 14 | 8 | -30 | 4 | 1 |
31 Mar 14 | 8 | -29 | 4 | 1 |
31 Dec 13 | 7 | -26 | 4 | 1 |
Quality Earnings: XXII is currently unprofitable.
Growing Profit Margin: XXII is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: XXII is unprofitable, and losses have increased over the past 5 years at a rate of 19.7% per year.
Accelerating Growth: Unable to compare XXII's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: XXII is unprofitable, making it difficult to compare its past year earnings growth to the Tobacco industry (2.4%).
Return on Equity
High ROE: XXII has a negative Return on Equity (-959.56%), as it is currently unprofitable.